The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Randomized controlled phase III trial to investigate superiority of robot-assisted gastrectomy over laparoscopic gastrectomy for clinical stage T1-2N0-2 gastric cancer patients: Japan Clinical Oncology Group study JCOG1907 (MONA LISA study).
 
Rie Makuuchi
No Relationships to Disclose
 
Mitsumi Terada
No Relationships to Disclose
 
Junki Mizusawa
Honoraria - Chugai Pharma; Taiho Pharmaceutical
 
Masanori Tokunaga
Honoraria - Intuitive Surgical; Johnson & Johnson; Kaken Pharmaceutical; Medtronic; Olympus Medical Systems; Ono Pharmaceutical; Taiho Pharmaceutical
 
Kei Hosoda
No Relationships to Disclose
 
Toshiyasu Ojima
No Relationships to Disclose
 
Takeshi Omori
No Relationships to Disclose
 
Kazuhisa Ehara
No Relationships to Disclose
 
Masaya Watanabe
No Relationships to Disclose
 
Akinori Takagane
No Relationships to Disclose
 
Yasunori Nishida
No Relationships to Disclose
 
Yoshitomo Yanagimoto
No Relationships to Disclose
 
Narikazu Boku
Honoraria - Bristol-Myers Squibb Japan; Ono Pharmaceutical; Taiho Pharmaceutical
Research Funding - Ono Pharmaceutical (Inst); Takeda (Inst)
 
Takaki Yoshikawa
Honoraria - Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; Chugai Pharma; Daiichi Sankyo; Lilly; Medtronic; Olympus; Ono Pharmaceutical; Taiho Pharmaceutical
Consulting or Advisory Role - MSD Oncology
Research Funding - Lilly
 
Masanori Terashima
Honoraria - Bristol-Myers Squibb; Chugai Pharma; Lilly; Nihonkayaku; Ono Pharmaceutical; Taiho Pharmaceutical
Research Funding - Ono Pharmaceutical (Inst)